О РОЛИ БИОМАРКЕРОВ В ВЕДЕНИИ ПАЦИЕНТОВ С ЮИА-АССОЦИИРОВАННЫМИ УВЕИТАМИ (ОБЗОР ЛИТЕРАТУРЫ)
Keywords:
ЮИА-ассоциированный увеит у детей, иммунологические биомаркеры, инвалидизация, белки, цитокины.Abstract
В данном обзоре систематизированы современные данные научной литературы за период с 2018 по 2025 годы о роли иммунологических биомаркеров в диагностике, прогнозировании и лечении увеита, ассоциированного с ЮИА.
References
Van Straalen JW, Giancane G, Amazrhar Y, Tzaribachev N, Lazar C, Uziel Y, et al. A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis. Rheumatology (Oxford). 2020;60(6). doi:10.1093/rheumatology/keaa733.
Angeles-Han ST, Yeh S, Vogler LB. Updates on the risk factors, treatment, and outcomes of juvenile idiopathic arthritis-associated uveitis. Curr Opin Rheumatol. 2020;32(5):395-402.
Heiligenhaus A, Minden K, Föll D, Pleyer U. Uveitis in juvenile idiopathic arthritis. Pediatrics. 2019;143(6):e20183307.
Ooi KG, Galatowicz G, Towler HM, Lightman SL, Calder VL. Multiplex cytokine detection versus ELISA for aqueous humor: IL-5, IL-10, and IFN-γ profiles in uveitis. Invest Ophthalmol Vis Sci. 2006;47(1):272-7. doi:10.1167/iovs.05-0790.
Lee IT, Lin CC, Wu YC, Yang CM. TNF-α induces matrix metalloproteinase-9 expression in A549 cells: role of TNFR1/TRAF2/PKCα-dependent signaling pathways. J Cell Physiol. 2010;224(2):454-64. doi:10.1002/jcp.22142.
Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology. 2001;108:2071-5. doi:10.1016/s0161-6420(01)00773-4.
Angeles-Han ST, McCracken C, Yeh S, et al. Characteristics of a cohort of children with juvenile idiopathic arthritis and JIA-associated uveitis. Pediatr Rheumatol Online J. 2015;13:19. doi:10.1186/s12969-015-0014-1.
Paroli MP, Spadea L, Pivetti-Pezzi P. Serum and aqueous IL-17 in JIA-associated uveitis. Clin Rheumatol. 2018;37(6):1625-30.
Miserocchi E, Pontikaki I, Galbiati M, Cimaz R. The predictive role of ANA in JIA-associated uveitis. Rheumatology (Oxford). 2020;59(8):2281-8.
Tappeiner C, Heinz C, Ganser G, Heiligenhaus A. Lactoferin in tears as marker of ocular inflammation. Br J Ophthalmol. 2019;103(5):646-51.
Drozdova EA, Tarasova LN, Teplova SN. Uveitis in rheumatic diseases. Moscow: T/T Publishing; 2010.
Drozdova EA, Teplova SN. Role of impaired immune regulation in the pathogenesis of uveitis associated with rheumatic diseases. Vestn Oftalmol. 2008;124(3):23-6. (in Russ).
Katargina LA, Khvatova AV. Endogenous uveitis in children and adolescents. Moscow: Meditsina; 2000.
Starikova AV. Clinical and immunological criteria for prognosis of uveitis associated with arthritis in children [dissertation abstract]. Moscow; 2003.
Tepikina EN. Significance of IL-17 in diagnosis and treatment of juvenile idiopathic arthritis in children [dissertation abstract]. Samara; 2011.
Trunov AN, Arbenyeva NS, Shvayuk AL, et al. Cytokine imbalance in tear fluid of patients with autoimmune uveitis. Vestn Orenburg Univ. 2013;153(4):270-3. (in Russ).
Khaitov RM. Immunology: structure and functions of the immune system. Moscow: GEOTAR-Media; 2013.
Edelsten C, Stanford M, Graham E. Epidemiology of visual loss in pediatric uveitis. In: XXXIX International Congress of Ophthalmology. Sydney; 2003. p. 138.
Edelsten C, Lee V, Bentley CR, Kanski JJ, Graham EM. Baseline risk factors predicting severity in juvenile idiopathic arthritis-associated uveitis. Br J Ophthalmol. 2002;86(1):51-6.
Foster H, Ramanan AV. The eyes have it! The need to improve awareness and access to early ophthalmological screening for JIA-associated uveitis. Rheumatology (Oxford). 2009;48(4):330-1.